Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension

被引：20
|
作者：
Perez-Villa, Felix [1 ]
Farrero, Marta [1 ]
Sionis, Alessandro [1 ]
Castel, Angeles [1 ]
Roig, Eulalia [1 ]
机构：
[1] Hosp Clin Barcelona, Thorax Inst, Heart Failure & Heart Transplantat Program, Barcelona, Spain
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2010年 / 29卷 / 07期
关键词：
D O I：
10.1016/j.healun.2010.02.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 818
页数：2
相关论文
共 50 条
  • [31] A heart transplant candidate with severe pulmonary hypertension and extremely high pulmonary vascular resistance
    Sato, Takuma
    Seguchi, Osamu
    Morikawa, Nagisa
    Hieda, Michinari
    Watanabe, Takuya
    Sunami, Haruki
    Murata, Yoshihiro
    Yanase, Masanobu
    Hata, Hiroki
    Fujita, Tomoyuki
    Nakatani, Takeshi
    JOURNAL OF ARTIFICIAL ORGANS, 2013, 16 (02) : 253 - 257
  • [32] Bosentan-sildenafil combination in the treatment of patients with severe pulmonary hypertension, and its effect on cardiac function
    Cui, Zhe
    Geng, Lin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (12) : 2619 - 2624
  • [33] Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension
    Shekerdemian, LS
    Ravn, HB
    Penny, DJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (08) : 1098 - 1102
  • [34] Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation
    Gómez-Moreno, S
    Lage, E
    Hernández, A
    Campos, A
    Cabezón, S
    Ordóñez, A
    Hinojosa, R
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (03) : 1550 - 1551
  • [35] Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension
    Schwartzmann, Pedro
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (02)
  • [36] Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension
    Price, Laura
    Kempny, Aleksander
    Mccabe, Colm
    Dimopoulos, Kostantinos
    Kotecha, Jalpa
    Harries, Carl
    Barbosa, Joana
    Hopkinson, Nick
    Simonds, Anita
    Wells, Athol
    Wort, John
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [37] Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
    Verlinden, Nathan J.
    Benza, Raymond L.
    Raina, Amresh
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [38] High Pulmonary Vascular Resistance in Pediatric Heart Transplant Patients and Role of Sildenafil
    Patel, P.
    Glumova, A.
    LaPorte, K.
    Mahle, W. T.
    Deshpande, S. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S270 - S270
  • [39] Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy
    Porhownik, Nancy R.
    Al-Sharif, Hassan
    Bshouty, Zoheir
    CANADIAN RESPIRATORY JOURNAL, 2008, 15 (08) : 427 - 430
  • [40] Initial Experience with Bosentan for the Management of Pulmonary Hypertension after Heart Transplantation
    Santiago, E.
    Farrero, M.
    Ivey-Miranda, J.
    Castel, M.
    Garcia-Alvarez, A.
    Perez-Villa, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S417 - S417
12345